No results for ‘’
Glaxosmithkline Pharmaceuticals Ltd
NSE: GLAXO BSE: 500660
₹2483.10
(1.15%)
Wed, 22 Jul 2026, 08:48 am
Market Cap (in Cr)41590.03
PE Ratio40.60
Dividend2.27
Health Technology
Pharmaceuticals: Major
24.5KGlaxosmithkline Pharmaceuticals Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 80615 | 1378.65 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 80615 | 1378.65 | 17 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11841 | 1378.65 | 17 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11841 | 1378.65 | 17 Oct 2022 |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 77734 | 1393.45 | 11 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11417 | 1393.45 | 11 Oct 2022 |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 77734 | 1393.45 | 11 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11417 | 1393.45 | 11 Oct 2022 |
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 11373 | 1424.4 | 03 Oct 2022 |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 11373 | 1424.4 | 03 Oct 2022 |
Showing 1–10 of 20
Rows per page: